- Additional Authors
- Docteur, Elizabeth.
- Description
- 66 p.; 21 x 29.7cm.
- Summary
- This paper describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals. Pharmaceutical coverage is comprehensive, with a high level of public funding, and ensures access to treatments. However, recent increases in out-of-pocket payments may impair affordability for the poorest part of the population. Germany does not regulate ex-manufacturer prices of pharmaceuticals at market entry (though distribution margins are regulated for reimbursed drugs). On the other hand, maximum reimbursement amounts (known as reference prices) are set for products which can be clustered in groups of equivalent (generic) or comparable products (...)
- Series Statement
- OECD Health Working Papers, 1815-2015 ; no.39
- Uniform Title
- OECD Health Working Papers, no.39.
- Subject
- LCCN
- 10.1787/228483137521
- OCLC
- oecd-lib-001347
- Author
Paris, Valérie.
- Title
Pharmaceutical Pricing and Reimbursement Policies in Germany [electronic resource] / Valérie Paris and Elizabeth Docteur
- Imprint
Paris : OECD Publishing, 2008.
- Series
OECD Health Working Papers, 1815-2015 ; no.39
OECD Health Working Papers, 1815-2015 ; no.39.
- Connect to:
- Indexed Term
Social Issues/Migration/Health
Germany
- Added Author
Docteur, Elizabeth.
- Other Standard Identifier
10.1787/228483137521 doi